UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 588

Sortiert nach

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease

PloS one, 2018-06, Vol.13 (6), p.e0199189-e0199189

2018

Volltextzugriff (PDF)

GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms

International journal of molecular sciences, 2023-05, Vol.24 (11), p.9183

Schneider, Jay S

2023

Volltextzugriff (PDF)

The neurobiological basis of cognitive impairment in Parkinson's disease

Movement disorders, 2014-04, Vol.29 (5), p.634-650

2014

Volltextzugriff (PDF)

Altered expression of glycobiology-related genes in Parkinson's disease brain

Frontiers in molecular neuroscience, 2022-11, Vol.15, p.1078854-1078854

2022

Volltextzugriff (PDF)

Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease

PloS one, 2015-04, Vol.10 (4), p.e0123231-e0123231

2015

Volltextzugriff (PDF)

siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegeneration

Molecular and cellular neuroscience, 2019-03, Vol.95, p.25-30

2019

Volltextzugriff (PDF)

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients

Journal of the neurological sciences, 2013-01, Vol.324 (1), p.140-148

2013

Volltextzugriff (PDF)

Gangliosides: Treatment Avenues in Neurodegenerative Disease

Frontiers in neurology, 2019-08, Vol.10, p.859

2019

Volltextzugriff (PDF)

Protection of dopaminergic cells from MPP+ -mediated toxicity by histone deacetylase inhibition

Brain research, 2010-10, Vol.1354, p.172-178

2010

Volltextzugriff (PDF)

Manganese: Recent advances in understanding its transport and neurotoxicity

Toxicology and applied pharmacology, 2007-06, Vol.221 (2), p.131-147

2007

Volltextzugriff (PDF)

Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease

PloS one, 2015-12, Vol.10 (12), p.e0143351-e0143351

2015

Volltextzugriff (PDF)

Sex-Dependent Effects of Developmental Lead Exposure on the Brain

Frontiers in genetics, 2018-03, Vol.9, p.89-89

2018

Volltextzugriff (PDF)

Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?

Environmental health perspectives, 2023-08, Vol.131 (8), p.85002-85002

Schneider, Jay S

2023

Volltextzugriff (PDF)

Response to "Comment on 'Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?'"

Environmental health perspectives, 2024-04, Vol.132 (4), p.48002

Schneider, Jay S

2024

Volltextzugriff (PDF)

Sex-dependent effects of lead and prenatal stress on post-translational histone modifications in frontal cortex and hippocampus in the early postnatal brain

Neurotoxicology (Park Forest South), 2016-05, Vol.54, p.65-71

2016

Volltextzugriff (PDF)

Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism

Journal of neurochemistry, 2008-12, Vol.107 (5), p.1236-1247

2008

Volltextzugriff (PDF)

Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates

Journal of neurochemistry, 2008-06, Vol.105 (5), p.1948-1959

2008

Volltextzugriff (PDF)

Current concepts in treating mild cognitive impairment in Parkinson's disease

Neuropharmacology, 2022-02, Vol.203, p.108880-108880, Article 108880

2022

Volltextzugriff (PDF)

Effects of the alpha-2 adrenoceptor agonist guanfacine on attention and working memory in aged non-human primates

The European journal of neuroscience, 2011-09, Vol.34 (6), p.1018-1022

2011

Volltextzugriff (PDF)

Different Behavioral Experiences Produce Distinctive Parallel Changes in, and Correlate With, Frontal Cortex and Hippocampal Global Post-translational Histone Levels

Frontiers in integrative neuroscience, 2018-07, Vol.12, p.29-29

2018

Volltextzugriff (PDF)

Effects of memantine and galantamine on cognitive performance in aged rhesus macaques

Neurobiology of aging, 2013-04, Vol.34 (4), p.1126-1132

2013

Volltextzugriff (PDF)

No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial

PloS one, 2014-12, Vol.9 (12), p.e112287

2014

Volltextzugriff (PDF)

GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease

Molecular and cellular neuroscience, 2022-05, Vol.120, p.103729-103729, Article 103729

2022

Volltextzugriff (PDF)

Developmental Lead Exposure and Prenatal Stress Result in Sex-Specific Reprograming of Adult Stress Physiology and Epigenetic Profiles in Brain

Toxicological sciences, 2018-06, Vol.163 (2), p.478-489

2018

Volltextzugriff (PDF)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease

Scientific reports, 2019-06, Vol.9 (1), p.8362, Article 8362

2019

Volltextzugriff (PDF)

1 – 25 von 588

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(470)
Mit Volltextzugriff
(496)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(586)
Japanisch
(64)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(326)
Life Sciences & Biomedicine
(258)
Humans
(161)
Male
(128)
Animals
(122)
Female
(104)
Biological And Medical Sciences
(78)
Neurosciences & Neurology
(77)
Middle Aged
(65)
Neurosciences
(59)
Medical Sciences
(54)
Aged
(52)
Adult
(48)
Mice
(38)
Neurology
(38)
Clinical Neurology
(31)
Multidisciplinary Sciences
(31)
Parkinson's Disease
(31)
Science & Technology - Other Topics
(31)
Technology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease

GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms

The neurobiological basis of cognitive impairment in Parkinson's disease

Altered expression of glycobiology-related genes in Parkinson's disease brain

Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease

siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegeneration

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients

Gangliosides: Treatment Avenues in Neurodegenerative Disease

Protection of dopaminergic cells from MPP+ -mediated toxicity by histone deacetylase inhibition

Manganese: Recent advances in understanding its transport and neurotoxicity

Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease

Sex-Dependent Effects of Developmental Lead Exposure on the Brain

Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?

Response to "Comment on 'Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?'"

Sex-dependent effects of lead and prenatal stress on post-translational histone modifications in frontal cortex and hippocampus in the early postnatal brain

Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism

Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates

Current concepts in treating mild cognitive impairment in Parkinson's disease

Effects of the alpha-2 adrenoceptor agonist guanfacine on attention and working memory in aged non-human primates

Different Behavioral Experiences Produce Distinctive Parallel Changes in, and Correlate With, Frontal Cortex and Hippocampal Global Post-translational Histone Levels

Effects of memantine and galantamine on cognitive performance in aged rhesus macaques

No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial

GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease

Developmental Lead Exposure and Prenatal Stress Result in Sex-Specific Reprograming of Adult Stress Physiology and Epigenetic Profiles in Brain

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease

Suchergebnisse filtern